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Introduction
BALB/c mice immunized with human cartilage proteogly-
can (PG) (aggrecan) develop arthritis [1–4]. Autoantibody
production precedes the first clinical symptoms of arthritis
[5]. While these anti-PG autoantibodies alone do not
transfer arthritis, autoantibodies significantly hasten the
onset of disease and cause PG to be released from the
cartilage [6,7].
B cells proliferate and differentiate into immunoglobulin-
secreting plasma cells under the influence of a combina-
tion of cytokines derived from T cells [8]. IL-4, a T helper
(Th)2 cytokine, regulates the switch from IgM/D to IgG1
and IgE in activated B cells [9,10]. However, the in vivo
dependency on IL-4 for the IgG1 response is controversial
[11–13]. The Th1 cytokine IFN-γ is important in vitro and
in vivo for enhancement of IgG2a secretion [14,15]. Th1
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and Th2 cytokines also function to cross-regulate Ig iso-
types. For example, IFN-γ antagonizes IL-4-induced IgG1
responses at the level of IgG1 transcription [16,17],
whereas IL-4 has the ability to suppress IFN-γ-driven
IgG2a responses [16].
We have previously shown that PG-specific antibodies
increase the severity of arthritis and that PG-induced
arthritis is a Th1-type disease dominated by IFN-γ [4]. We
therefore were interested in finding out how IFN-γ and IL-4
regulate isotype expression of the PG-specific antibodies
and if an autoantibody isotype contributes to the severity
of disease.
Materials and methods
Animals
BALB/c and IFN-γ-deficient mice were purchased from
the Jackson Laboratory (Bar Harbor, ME, USA). BALB/c
heterozygous and homozygous nude mice were obtained
from the National Cancer Institute (Frederick, MD, USA).
Breeding pairs of BALB/c IL-4-deficient mice were
obtained from Klinische Forschergruppe für Rheumatolo-
gie (Freiburg, Germany). CD40-deficient BALB/c mice
were purchased from Taconic (Germantown, NY, USA).
Preparation of cartilage PG monomer (aggrecan) and
immunization
Human cartilage was obtained during joint-replacement
surgery and high-density PG was prepared as described
elsewhere [1,5]. Female BALB/c mice (wild-type or gene
deficient) were injected intraperitoneally on days 0, 21,
and 42 with 100 µg of human cartilage PG measured as
protein, in adjuvant, as described elsewhere [1,2,5].
Measurement of immunoglobulin isotypes
Enzyme-linked immunosorbent assay (ELISA) was used to
measure isotype-specific antibodies in serial dilutions
(1:1000 to 1:62,500) of sera. ELISA plates were coated
with either 0.5 µg human PG or 1 µg mouse PG, as
described elsewhere [5,18]. PG-specific IgG isotypes
were detected with peroxidase-labeled rabbit anti-mouse
IgG1 or IgG2a (Zymed Laboratories, San Francisco, CA,
USA). IgG1 and IgG2a myeloma proteins were used for a
standard curve.
Assessment of cytokine production by spleen cells in vitro
Spleens were obtained 1 week after the third injection
with PG, as described elsewhere [4]. Cells were stimu-
lated in the presence or absence of PG (20 µg/ml) and a
capture ELISA was used to measure the released
cytokines IFN-γ, IL-4, and IL-10 [4].
Assessment of arthritis
The severity of arthritis in each paw was graded according
to an established scoring system [3,5] as follows: 0, normal;
1, mild erythema and/or swelling, usually in one or two toes;
2, moderate erythema and/or swelling of the paw; 3, more
diffuse erythema; 4, severe erythema and swelling affecting
the entire paw (maximum score for the four paws = 16).
Inflammation and joint swelling were recorded twice a week
by the same individual in a blinded manner.
Statistical analysis
The Mann–Whitney U test was used to compare nonpara-
metric data for statistical significance. P values less than
0.05 were considered significant.
Results
PG-specific IgG1 isotype dominates despite a higher
ratio of IFN-γ to IL-4
BALB/c mice immunized with human PG generated a PG-
specific IgG1 isotype response which was significantly
higher than the PG-specific IgG2a isotype (Fig. 1a).
However, when the production of Th1 and Th2 cytokines
was measured from splenocytes of animals immunized
with PG, IFN-γ was produced at a significantly higher con-
centration than either IL-4 or IL-10 (Fig. 1a). These results
reveal a dichotomy between the isotype of the PG-specific
antibody response (IgG1) and the secretion of IFN-γ. The
discrepancy could be reconciled if the PG-specific IgG1
response is independent of T cells.
We therefore assessed the PG-specific response in het-
erozygous and homozygous nude mice and in CD40-defi-
cient mice. Whereas heterozygous nude mice generated
essentially the same antibody response to PG as wild-type
mice (Fig. 1b), no or very little anti-PG antibody was
detected in homozygous nude or CD40-deficient mice
(Fig. 1b). These results show that the human and murine
PG-specific antibody responses are dependent on the
interaction between T cells and B cells.
IL-4 and IFN-γ γ regulation of the PG-specific IgG1/IgG2a
isotype response
To find out if the PG-specific IgG1 response is dependent
on IL-4, we immunized IL-4-deficient mice with PG and
measured the PG-specific IgG1 and IgG2a isotypes.
Whereas the IgG1 response to human PG was unaffected
(Fig. 2a), the loss of IL-4 significantly reduced the IgG1
response to mouse PG in IL-4-deficient mice (Fig. 2b).
The most striking observation, however, was the dramatic
increase in PG-specific IgG2a response in IL-4 deficient
mice. There was a sixfold increase in the IgG2a response
in the absence of IL-4 (Fig. 2a,b). These results show that
the PG-specific IgG1 response was marginally dependent
on IL-4, whereas endogenous IL-4 dramatically sup-
pressed the PG-specific IgG2a response.
To find out if IFN-γ induced a PG-specific IgG2a response
in vivo, the PG-specific IgG2a response was examined in
IFN-γ-deficient mice. The IgG2a antibody responses to
both human and mouse PGs were lower in these miceArthritis Research    Vol 4 No 1 Kaplan et al.
than in wild-type mice (Fig. 2a,b). These results show that
the PG-specific IgG2a response was dependent on IFN-γ.
If IFN-γ concentrations regulated IgG1, reduction in IFN-γ
should be permissive for IgG1; in IFN-γ-deficient mice,
however, there was no increase in IgG1 response to either
human or mouse PG (Fig. 2a,b).
Arthritis is associated with an increase in IgG2a
We studied the induction of arthritis in mice deficient in
IL-4 and IFN-γ to find out if there is a correlation between
the isotype of the antibody and disease. In wild-type and
IL-4 deficient mice, paw swelling began 11.6 ± 6.6 days
after the last injection with PG, whereas in the IFN-γ-defi-
cient mice, swelling began much later at 36.8 ± 6.2 days
(Table 1). The incidences of arthritis in wild-type and IL-4-
deficient mice were much higher than in the PG-immu-
nized IFN-γ-deficient mice, and the arthritis score was
significantly higher in the IL-4-deficient than in the wild-
type animals (Table 1). In IFN-γ-deficient mice, not only
Figure 2
Production of PG-specific IgG2a isotype is increased in IL-4-deficient
mice. Wild-type, IL-4-deficient, and IFN-γ-deficient mice were
immunized with PG, and serum antibody isotypes to human PG (a) or
mouse PG (b) were measured by ELISA. Values are means; whiskers
indicate SEM. PG = proteoglycan; WT = wild-type. *P < 0.05 in
comparison with wild-type mice.
Figure 1
PG-specific antibody isotypes and cytokines in PG-induced arthritis.
(a) Serum concentrations of PG-specific IgG1 and IgG2a isotypes
and production of PG-specific cytokines by spleen cells of PG-
immunized mice. PG-specific (anti-human and anti-mouse) isotypes
were measured in sera (N = 30) and cytokines in supernatants of
spleen cells (N = 5). (b) T-cell-deficient (nude) and CD40-deficient
mice did not generate a PG-specific antibody response. Heterozygous
and homozygous nude and CD40-deficient mice were immunized with
PG. Note: Scales for antibody concentrations differ between panels A
and B. Values are means; whiskers indicate SEM. h, m = respectively,
antibodies to human and mouse PG; PG = proteoglycan. *P < 0.05 in
comparison with heterozygous nude mice.was the proportion of animals with arthritis lower than in
the other groups, but also their reduced susceptibility was
further mirrored in the significantly less severe paw
swelling (Table 1). These data show that endogenous
cytokine concentrations dramatically affect both the onset
and the severity of inflammation.
Discussion
Because PG-induced arthritis is dominated by IFN-γ, it is
considered to be a Th1-type disease [4,18]. Paradoxically,
we observed higher concentrations of the IgG1 isotype
than of the IgG2a isotype. To resolve this apparent
paradox, we examined the anti-PG responses in cytokine-
deficient animals. We found that in the absence of IL-4,
the PG-specific IgG1 isotype was only minimally affected.
These in vivo experiments are very different from those
describing a dramatic in vitro effect of IL-4 on IgG1 induc-
tion [9,10], but are similar to other studies that showed
partial elimination of IgG1 in vivo, either using neutralizing
antibodies to IL-4 or blocking the IL-4 receptor with anti-
bodies [11–13,19]. One possibility was that the large
carbohydrate content of PG might have a promoting inter-
action with B cells in a mitogen-like manner, thus permit-
ting production of IgG1. However, nude mice and
CD40-deficient mice did not generate a PG-specific IgG1
response and such a response was also independent of
IFN-γ. Taken together, these results are in contrast to the
IL-4-dictated IgG1 switch response. Rather, they suggest
that the PG-specific IgG1 response, at least in BALB/c
mice, may be regulated in vivo by other, as-yet-unidenti-
fied, cytokine(s) [8,20–22].
In contrast to IgG1, the expression of IgG2a isotype
showed a strong inverse correlation with the concentra-
tion of endogenous IL-4. In the absence of IL-4, the IgG2a
response was six times greater than in wild-type mice. This
finding demonstrates that IL-4 plays a critical role in regu-
lating the PG-specific IgG2a response. The role of this
cytokine in the suppression of IgG2a in vivo has not been
well studied. The IgG2a response was only minimally
enhanced after in vivo treatment with anti-IL-4 antibody
[8], but it was increased in immunized IL-4-deficient mice
[23]. Since there is no evidence that IL-4 directly inhibits
IgG2a transcription in B cells, this cytokine very likely sup-
presses the IFN-γ response, either directly or indirectly.
Indeed, the significant reduction of the PG-specific IgG2a
response in the absence of IFN-γ suggests that the
response is controlled by this interferon.
We have found that the development of PG-specific anti-
bodies correlates with the development of arthritis, and
that PG-specific autoantibodies increase the severity of
disease. We show here that mice deficient in IL-4 develop
arthritis that is significantly more severe than in wild-type
animals. The pathogenic role of IgG2a antibody was also
described in a model of autoimmune hemolytic anemia
[24]; however, these IgG2a autoantibodies were not
pathogenic in mice that are deficient in Fcγ receptor III
[24]. These two observations taken together suggest the
possibility that the IgG2a PG-specific autoantibodies elicit
a pathogenic effect through an Fc-receptor-mediated
mechanism.
PG-induced arthritis is considered a Th1-type disease,
characterized by a higher ratio of IFN-γ to IL-4 [4]. Our
finding that treatment with IL-4 inhibits IFN-γ suggests that
IL-4 could mediate a shift from a Th1 to a Th2 response in
vivo [4]. In addition to the effects of IL-4 on antibody pro-
duction, this cytokine inhibits Th1 responses, including
IFN-γ and macrophage production of proinflammatory
cytokines [25,26]. An increase in inflammatory cytokine
production in IL-4-deficient mice may also contribute to
exacerbation of PG-induced arthritis. In adjuvant arthritis,
which may not be dependent on antibodies, disease is
increased in the absence of IL-4 [27]. This finding sug-
gests that IL-4 inhibits adjuvant arthritis by its anti-inflam-
matory properties and not by an alteration in isotype
expression. Paradoxically, in collagen-induced arthritis
(CIA), disease is suppressed in IL-4-deficient mice [28].
CIA is also different from PG-induced arthritis in regard to
IFN-γ. In CIA and some other organ-specific autoimmune
diseases, IFN-γ functions in a protective role, so that in
IFN-γ-deficient mice disease is exacerbated [29,30].
Whether the difference between PG-induced arthritis and
CIA is due to the autoantigen or to genetic differences in
mouse strains is not clear at present.
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Table 1
Arthritis is exacerbated in IL-4-deficient mice and suppressed in IFN-γ-deficient mice
Mice Incidence (arthritis/total) (%) Arthritis score of diseased micea Day of onsetb
Wild-type 9/12 (75) 5.2 ± 2.5 11.8 ± 6.6
IL-4–/– 9/9 (100) 9.6 ± 1.1* 9.5 ± 6.0
IFN-γ–/– 5/22 (22) 2.4 ± 2.0* 36.8 ± 6.2**
aMean arthritic score for wild-type and IL-4-deficient mice was maximum at day 23 and for the IFN-γ-deficient mice at day 41 after the last
immunization with PG. bDays from last immunization with PG to onset of disease. *Score differed significantly from that for wild-type mice 
(P < 0.05). **Time to onset of disease differed significantly from that in wild-type mice (P < 0.002).Arthritis Research    Vol 4 No 1 Kaplan et al.
Conclusion
Th1 and Th2 cytokines regulate PG-specific autoantibody
IgG isotypes and susceptibility to arthritis. In the absence
of IL-4, the production of PG-specific IgG2a isotype was
dramatically enhanced and disease was significantly more
severe. IL-4 may exert its effect through IFN-γ, since in
IFN-γ-deficient mice, both the PG-specific IgG2a
response and arthritis were suppressed. The correlation
between PG-specific autoantibody isotype and develop-
ment of arthritis suggests a pathological role for IgG2a
isotype in disease.
Acknowledgements
This work was supported by the National Institutes of Health grant
AR45652.
References
1. Glant TT, Mikecz K, Arzoumanian A, Poole AR: Proteoglycan-
induced arthritis in BALB/c mice. Clinical features and
histopathology. Arthritis Rheum 1987, 30:201-212.
2. Mikecz K, Glant TT, Poole AR: Immunity to cartilage proteogly-
cans in BALB/c mice with progressive polyarthritis and anky-
losing spondylitis induced by injection of human cartilage
proteoglycan. Arthritis Rheum 1987, 30:306-318.
3. Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K: Progres-
sive polyarthritis induced in BALB/c mice by aggrecan from
normal and osteoarthritic human cartilage. Arthritis Rheum
1998, 41:1007-1018.
4. Finnegan A, Mikecz K, Tao P, Glant TT: Proteoglycan (Aggre-
can)-induced arthritis in BALB/c mice is a Th1-type disease
regulated by Th2 cytokines. J Immunol 1999, 163:5383-5390.
5. Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz
K: Critical roles of glycosaminoglycan side chains of cartilage
proteoglycan (aggrecan) in antigen recognition and presenta-
tion. J Immunol 1998, 160:3812-3819.
6. Mikecz K, Glant TT, Buzas E, Poole AR: Proteoglycan-induced
polyarthritis and spondylitis adoptively transferred to naive
(nonimmunized) BALB/c mice. Arthritis Rheum1990, 33:866-
876.
7. Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR: Cartilage pro-
teoglycan-induced arthritis in BALB/c mice. Antibodies that
recognize human and mouse cartilage proteoglycan and can
cause depletion of cartilage proteoglycan with little or no syn-
ovitis. Arthritis Rheum 1990, 33:1394-1405.
8. Finkelman FD, Holmes J, Katona IM, Urban JF, Jr., Beckmann MP,
Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lym-
phokine control of in vivo immunoglobulin isotype selection.
Annu Rev Immunol 1990, 8:303-333.
9. Paul WE: Interleukin-4: a prototypic immunoregulatory lym-
phokine. Blood 1991, 77:1859-1870.
10. Snapper CM, Finkelman FD, Paul WE: Regulation of IgG1 and
IgE production by interleukin 4. Immunol Rev 1988, 102:51-75.
11. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E: IL-4 is required for
the IgE and IgG1 increase and IgG1 autoantibody formation in
mice treated with mercuric chloride. J Immunol 1991,  146:
3006-3011.
12. Finkelman FD, Urban JF, Jr., Beckmann MP, Schooley KA, Holmes
JM, Katona IM: Regulation of murine in vivo IgG and IgE
responses by a monoclonal anti-IL-4 receptor antibody. Int
Immunol 1991, 3:599-607.
13. Estes DM, Teale JM: In vivo effects of anticytokine antibodies
on isotype restriction in Mesocestoides corti-infected BALB/c
mice. Infect Immun 1991, 59:836-842.
14. Finkelman FD, Katona IM, Mosmann TR, Coffman RL: IFN-
gamma regulates the isotypes of Ig secreted during in vivo
humoral immune responses. J Immunol 1988, 140:1022-1027.
15. Snapper CM, Peschel C, Paul WE: IFN-gamma stimulates
IgG2a secretion by murine B cells stimulated with bacterial
lipopolysaccharide. J Immunol 1988, 140:2121-2127.
16. Snapper CM, Paul WE: Interferon-gamma and B cell stimula-
tory factor-1 reciprocally regulate Ig isotype production.
Science 1987, 236:944-947.
17. Berton MT, Uhr JW, Vitetta ES: Synthesis of germ-line gamma
1 immunoglobulin heavy-chain transcripts in resting B cells:
induction by interleukin 4 and inhibition by interferon gamma.
Proc Natl Acad Sci U S A 1989, 86:2829-2833.
18. Hollo K, Glant TT, Garzo M, Finnegan A, Mikecz K, Buzas E:
Complex pattern of Th1 and Th2 activation with a preferential
increase of autoreactive Th1 cells in BALB/c mice with pro-
teoglycan (aggrecan)-induced arthritis. Clin Exp Immunol
2000, 120:167-173.
19. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM,
Cheever AW, Paul WE, Sher A: Schistosome-infected IL-4
receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to
develop granulomatous pathology while maintaining the same
lymphokine expression profile. J Immunol 1999, 163:337-342.
20. Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert
B, Caspi RR: IFN-gamma-deficient mice develop experimental
autoimmune uveitis in the context of a deviant effector
response. J Immunol 1997, 158:5997-6005.
21. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Bra-
ciale TJ: Response to influenza infection in mice with a tar-
geted disruption in the interferon gamma gene. J Exp Med
1993, 178:1725-1732.
22. Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B,
Hultman P, Pollard KM: The prototypic Th2 autoimmunity
induced by mercury is dependent on IFN- gamma and not
Th1/Th2 imbalance. J Immunol 1998, 161:234-240.
23. Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J:
In interleukin-4-deficient mice, alum not only generates T
helper 1 responses equivalent to freund’s complete adjuvant,
but continues to induce T helper 2 cytokine production. Eur J
Immunol 1996, 26:2062-2066.
24. Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y,
Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C,
Schmidt RE, Honjo T, Verbeek JS, Izui S: Markedly different
pathogenicity of four immunoglobulin G isotype-switch vari-
ants of an antierythrocyte autoantibody is based on their
capacity to interact in vivo with the low-affinity Fcgamma
receptor III. J Exp Med 2000, 191:1293-1302.
25. Gautam S, Tebo JM, Hamilton TA: IL-4 suppresses cytokine
gene expression induced by IFN-γ γ and/or IL-2 in murine peri-
toneal macrophages. J Immunol 1992, 148:1725-1730.
26. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Liv-
ingston DM, Kung AL, Cereb N, Yao T-P, Yang Sy, Reiner SL:
Role of T-bet in commitment of Th1 cells before IL-12-depen-
dent selection. Science 2001, 292:1907-1910.
27. Yoshino S Murata Y, Ohsawa M: Successful induction of adju-
vant arthritis in mice by treatment with a monoclonal antibody
against IL-4. J Immunol 1998, 161:6904-6907.
28. Ortmann RA, Shevach EM: Susceptibility to collagen-induced
arthritis: cytokine-mediated regulation. Clin Immunol 2001, 98:
109-118.
29. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A,
Matthys P: Accelerated collagen-induced arthritis in IFN-gamma
receptor-deficient mice. J Immunol 1997, 158:5507-5513.
30. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O,
Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High sus-
ceptibility to collagen-induced arthritis in mice lacking IFN-
gamma receptors. J Immunol 1997, 158:5501-5506.